Major Depressive Disorder Clinical Trials Database - Free Access to 1,198 Studies
Access comprehensive clinical trial information for Major Depressive Disorder through Pure Global AI's free database. This collection includes 1,198 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 209 trials are actively recruiting participants.
Research for Major Depressive Disorder is being conducted in United States of America, China, Canada and 7+ other countries. Leading sponsors include H. Lundbeck A/S and Massachusetts General Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Study to evaluate the efficacy and safety of Paxil® Tablets in children and adolescents with Major Depressive Disorder
A study to determine the safety and efficacy of duloxetine in the treatment of children and adolescents with depression.
Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Children And Adolescent Outpatients With Major Depressive Disorder
Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder
Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder
Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder
A study to evaluate the safety and tolerability and to assess blood levels of seltorexant in adolescents with Major Depressive Disorder who have not responded well to their current antidepressant and psychotherapy
Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression
Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol
New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)
Regulation of Affect and Physiology in Depression
Standardized Assessment in Depression Treatment in Routine Psychiatric Services
Pharmacologic Treatment Augmentation in Chronic Depression
Whole-body Hyperthermia for Depression
Application of the Web-based Acceptance and Commitment Therapy for Depression
A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder
Behavioral Activation for Depression and Habitual Rumination
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
Pure Global AI provides free access to 1,198 clinical trials studying Major Depressive Disorder, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include H. Lundbeck A/S, Massachusetts General Hospital, Eli Lilly and Company, among others.